slideshow 1 slideshow 2 slideshow 3 slideshow 4 slideshow 5 slideshow 6


Equilab International, PT was established in November 2002. Through incessant research and innovation this company dedicated to provides services in Bioavailability/Bioequivalence (BA/BE) study and comprehensive Clinical Trial. To fulfill these need, Equilab develops two business area, BA/BE Unit and Clinical Research Unit. As Bioequivalence Studies laboratory, our BA/BE Unit is the first ISO 17025:2005 accredited BA/BE laboratory in Indonesia and offers a lot numbers of bioanalytical capabilities with validated and accredited status. Our Clinical Research Unit provides wide range of clinical trial activities. Another services provided is comparative dissolution testing to support successful BE study by assessing drug equivalency in in-vitro condition.

BPOM Visit to Equilab’s Renovated Facility

The National Agency of Drug and Food Control of Republic Indonesia (BPOM RI) was visiting PT Equilab International office in Jl. RS Fatmawati Persil 33 Cilandak, Jakarta Selatan at Monday, April 9th, 2018.